DexCom's growth trend improved in 1Q25, but competition and shrinking market potential keep upside limited. Find out why DXCM ...

World Acceptance Corporation excels in the fragmented small-loan consumer finance industry. Click here to read why WRLD stock ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

Montage Gold is advancing its low-cost, long-life Koné project amid a secular gold bull market and rapid construction ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

It remains to be seen how the new management team will lead Patriot National Bancorp. Click here to read why PNBK stock is a ...

LCI Industries has seen margins come in below long-term averages. Click here to read more about LCII stock and why it is a ...

FFA offers a blend of capital appreciation and consistent income, with a 7.3% dividend yield. Click here to read why I rate ...

SNDL Inc. is considering different listing options to enhance its involvement in US cannabis markets. Read why I change my ...

The Bloomberg US Credit Index returned +2.36% for the quarter. A bull-steepening UST yield curve more than offset the ...

Nvidia faces competition from high-tech majors, risking market share and profit margins. Read why I remain neutral on NVDA ...

Lumen Technologies pivots to AI infrastructure, reduces debt, and projects $3.5B+ EBITDA by 2026. Read why LUMN stock is a ...